InvestorsHub Logo

runncoach

02/21/17 9:28 AM

#1092 RE: SF Wolf #1091

I agree with that assessment wolf. Most posters on this board invested due to the science of the mouse models... models that actually measured that increases in synaptic growth. Finding out the compassionate use results last week only confirmed that science too many of us. This stock will have 14 million shares fully diluted and tens of millions of cash in the bank if it comes to that. That's about as simple as it can be stated I think. Big Pharma will fund the next round of studies if the results are as good as the CEO thinks they will be in April. That's my guess

Maple tree

02/21/17 10:12 AM

#1096 RE: SF Wolf #1091

Agree with you. NTRP has a solid scientic foundation and has much better chance than any other competititors to succeed in development of robust AD drug.

Cbdpotential

02/21/17 11:52 AM

#1101 RE: SF Wolf #1091

Great post
Thank you